We are monitoring the impact of COVID-19 on Europe Preimplantation Genetic Testing Market Get in touch with us for detailed analysis Know More
Pulished Date August, 2019
ID: 6674
Share on
Share on

Europe Preimplantation Genetic Testing Market Research Report - Segmented By Procedure Type, By Technology, By Products & Services, By Application, By End User & By Country(UK, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands, Turkey, Czech Republic and Rest of Europe) - Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2019-2024)

Pulished: August, 2019
ID: 6674
Pages: 145

Europe Preimplantation Genetic Testing Market Size & Growth (2019 - 2024)

As per the research report, the size of the Europe Preimplantation Genetic Testing Market is valued at USD xx million in 2019 and estimated to be growing at a CAGR of xx%, to reach USD xx million by 2024 during the forecast period 2019-2024.

Preimplantation genetic detection is a method that examines the embryos that are creating using the process of in vitro fertilization. This facilitates the implantation of only selected fit embryos into the uterus thus making sure that a healthy baby is delivered. This prevents the carrying of genetic disorders into the family generations. The testing is done by a screening process wherein the healthy ones are frozen and stored.

The increasing occurrence of infertility around the world, growing support from public and private organizations in this field, rising medical facilities catering to patients with fertility issues, advancing technology in the field of genetics, awareness about chromosomal anomalies with the growing age of mother are all the factors that can be attributed to the growth of the preimplantation genetic testing market.

This research report segmented and sub-segmented into the following categories:

  • By Procedure Type: Genetic Diagnosis, Genetic Screening
  • By Technology: NGS, PCR, FISH, CGH, SNP
  • By Products & Services: Reagents And Consumables, Instruments, Software And Services
  • By Application: Structural Chromosomal Abnormalities, Single Gene Disorders, X-Linked Disorders, HLA Typing, Gender Identification
  • By End User: Fertility Clinics, Hospitals, And Research Laboratories
  • By Country: UK, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands, Turkey, Czech Republic and Rest of Europe

This region, because of increased focus on the R & D sector is expected to grow significantly in the future. The high financial status is also proposed to contribute to growth.

Key players operating in the Europe Preimplantation Genetic Testing Market profiled in this report are Illumina, Inc., Yikon Genomics, CooperSurgical, Oxford Gene Technology, Inc., Thermo Fisher Scientific, Inc., Rubicon Genomics, Inc., Agilent Technologies, Inc., Natera, Inc., Abbott Laboratories, PerkinElmer, Inc., and SciGene Corporation.

1. Introduction         

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods  

                1.4 General Study Assumptions                

2. Research Methodology                   

                2.1 Introduction       

                2.2 Research Phases                      

        2.2.1 Secondary Research           

        2.2.2 Primary Research 

        2.2.3 Econometric Modelling      

        2.2.4 Expert Validation  

                2.3 Analysis Design 

                2.4 Study Timeline  

3. Overview               

                3.1 Executive Summary                

                3.2 Key Inferences 

                3.3 Epidemology      

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)            

                4.1 Market Drivers  

                4.2 Market Restraints                    

                4.3 Key Challenges 

                4.4 Current Opportunities in the Market      

5. Market Segmentation                      

                5.1 Procedure Type

        5.1.1 Introduction           

        5.1.2 Preimplantation Genetic Screening              

        5.1.3 Preimplantation Genetic Screening              

        5.1.4  Y-o-Y Growth Analysis, By Procedure Type              

        5.1.5  Market Attractiveness Analysis, By Procedure Type            

        5.1.6  Market Share Analysis, By Procedure Type              

                5.2 Technology                 

        5.2.1 Introduction           

        5.2.2 Next-Generation Sequencing         

        5.2.3 Polymerase Chain Reaction             

        5.2.4 Validation Biomarkers        

        5.2.5 Fluorescence in Situ Hybridization

        5.2.6 Comparative Genomic Hybridization           

        5.2.7 Single-Nucleotide Polymorphism  

        5.2.8 Y-o-Y Growth Analysis, By Technology        

        5.2.9 Market Attractiveness Analysis, By Technology      

        5.2.10 Market Share Analysis, By Technology     

                5.3 Product and Service        

        5.3.1 Introduction           

        5.3.2 Reagents and Consumables            

        5.3.3 Instruments           

        5.3.4 Software and Services       

        5.3.5 Y-o-Y Growth Analysis, By Product and Service       

        5.3.6  Market Attractiveness Analysis, By Product and Service    

        5.3.7  Market Share Analysis, By Product and Service      

                5.4 Application                 

        5.4.1 Introduction           

        5.4.2 Aneuploidy             

        5.4.3 Structural Chromosomal Abnormalities      

                        5.4.3.1 Translocations

                        5.4.3.2 Deletions

                        5.4.3.3 Duplications

                        5.4.3.4 Inversions

        5.4.4 Single Gene Disorders        

        5.4.5 X-Linked Disorders              

        5.4.6 HLA Typing              

        5.4.7 Gender Identification         

        5.4.8 Y-o-Y Growth Analysis, By Application         

        5.4.9  Market Attractiveness Analysis, By Application      

        5.4.10  Market Share Analysis, By Application     

                5.5 End users                    

        5.5.1 Introduction           

        5.5.2 Maternity Centers & Fertility Clinics             

        5.5.3 Hospitals, Diagnostic Labs, and Service Providers   

        5.5.4 Research Laboratories & Academic Institutes          

        5.5.5 Y-o-Y Growth Analysis, By End users            

        5.5.6  Market Attractiveness Analysis, By End users         

        5.5.7 Market Share Analysis, By End users           

6. Geographical Analysis                      

                6.1 Introduction       

        6.1.1 Regional Trends    

        6.1.2 Impact Analysis     

        6.1.3 Y-o-Y Growth Analysis        

                        6.1.3.1 By Geographical Area

                        6.1.3.2 By Procedure type

                        6.1.3.3 By Technology

                        6.1.3.4 By Product and Service

                        6.1.3.5 By Application

                        6.1.3.6 By End user

        6.1.4  Market Attractiveness Analysis     

                        6.1.4.1 By Geographical Area

                        6.1.4.2 By Procedure type

                        6.1.4.3 By Technology

                        6.1.4.4 By Product and Service

                        6.1.4.5 By Application

                        6.1.4.6 By End user

        6.1.5  Market Share Analysis      

                        6.1.5.1 By Geographical Area

                        6.1.5.2 By Procedure type

                        6.1.5.3 By Technology

                        6.1.5.4 By Product and Service

                        6.1.5.5 By Application

                        6.1.5.6 By End user

                6.2 U.K                 

                6.3 Spain     

                6.4 Germany                     

                6.5 Italy       

                6.6 France  

7. Strategic Analysis               

                7.1 PESTLE analysis 

        7.1.1 Political     

        7.1.2 Economic 

        7.1.3 Social         

        7.1.4 Technological         

        7.1.5 Legal          

        7.1.6 Environmental       

                7.2 Porter’s Five analysis      

        7.2.1 Bargaining Power of Suppliers        

        7.2.2 Bargaining Power of Consumers    

        7.2.3 Threat of New Entrants     

        7.2.4 Threat of Substitute Products and Services              

        7.2.5 Competitive Rivalry within the Industry     

8. Market Leaders' Analysis                

                8.1 Illumina, Inc.      

        8.1.1 Overview 

        8.1.2 Product Analysis   

        8.1.3 Financial analysis  

        8.1.4 Recent Developments       

        8.1.5 SWOT analysis       

        8.1.6 Analyst View          

                8.2 Thermo Fisher Scientific Inc.       

                8.3 Agilent Technologies, Inc.                    

                8.4 Perkinelmer, Inc.                     

                8.5 Coopersurgical, Inc.        

                8.6 ABBott Laboratories       

                8.7 Natera, Inc.                

                8.8 Rubicon Genomics, Inc. 

9. Competitive Landscape                   

                9.1 Market share analysis    

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, collaborations and Joint Ventures 

                9.4 New Product Launches 

10. Market Outlook and Investment Opportunities                 

Appendix                   

                a) List of Tables                

                b) List of Figures      

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in By Procedure Typewith market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analyzing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Europe Preimplantation Genetic Testing Market By Procedure Type, From 2019-2024 ( USD Million )
  2. Europe Preimplantation Genetic Screening Market By Region, From 2019-2024 ( USD Million )
  3. Europe Preimplantation Genetic Diagnosis Market By Region, From 2019-2024 ( USD Million )
  4. Europe Preimplantation Genetic Testing Market By Technology , From 2019-2024 ( USD Million )
  5. Europe Next-Generation Sequencing Market By Region, From 2019-2024 ( USD Million )
  6. Europe Polymerase Chain Reaction Market By Region, From 2019-2024 ( USD Million )
  7. Europe Fluorescence in Situ Hybridization Market By Region, From 2019-2024 ( USD Million )
  8. Europe Comparative Genomic Hybridization Market By Region, From 2019-2024 ( USD Million )
  9. Europe Single-Nucleotide Polymorphism Market By Region, From 2019-2024 ( USD Million )
  10. Europe Preimplantation Genetic Testing Market By Product and Service, From 2019-2024 ( USD Million )
  11. Europe Reagents and Consumables Market By Region, From 2019-2024 ( USD Million )
  12. Europe Instruments Market By Region, From 2019-2024 ( USD Million )
  13. Europe Software and Services Market By Region, From 2019-2024 ( USD Million )
  14. Europe Preimplantation Genetic Testing Market By Application , From 2019-2024 ( USD Million )
  15. Europe Aneuploidy Market By Region, From 2019-2024 ( USD Million )
  16. Europe Structural Chromosomal Abnormalities Market By Region, From 2019-2024 ( USD Million )
  17. Europe Single Gene Disorders Market By Region, From 2019-2024 ( USD Million )
  18. Europe X-Linked Disorders Market By Region, From 2019-2024 ( USD Million )
  19. Europe HLA Typing Market By Region, From 2019-2024 ( USD Million )
  20. Europe Gender Identification Market By Region, From 2019-2024 ( USD Million )
  21. Europe Preimplantation Genetic Testing Market By End User , From 2019-2024 ( USD Million )
  22. Europe Maternity Centers & Fertility Clinics Market By Region, From 2019-2024 ( USD Million )
  23. Europe Hospitals, Diagnostic Labs, and Service Providers Market By Region, From 2019-2024 ( USD Million )
  24. Europe Research Laboratories & Academic Institutes Market By Region, From 2019-2024 ( USD Million )
  25. U.K. Preimplantation Genetic Testing Market By Procedure Type, From 2019-2024 ( USD Million )
  26. U.K. Preimplantation Genetic Testing Market By Technology , From 2019-2024 ( USD Million )
  27. U.K. Preimplantation Genetic Testing Market By Product and Service, From 2019-2024 ( USD Million )
  28. U.K. Preimplantation Genetic Testing Market By Application , From 2019-2024 ( USD Million )
  29. U.K. Preimplantation Genetic Testing Market By End User , From 2019-2024 ( USD Million )
  30. Germany Preimplantation Genetic Testing Market By Procedure Type, From 2019-2024 ( USD Million )
  31. Germany Preimplantation Genetic Testing Market By Technology , From 2019-2024 ( USD Million )
  32. Germany Preimplantation Genetic Testing Market By Product and Service, From 2019-2024 ( USD Million )
  33. Germany Preimplantation Genetic Testing Market By Application , From 2019-2024 ( USD Million )
  34. Germany Preimplantation Genetic Testing Market By End User , From 2019-2024 ( USD Million )
  35. France Preimplantation Genetic Testing Market By Procedure Type, From 2019-2024 ( USD Million )
  36. France Preimplantation Genetic Testing Market By Technology , From 2019-2024 ( USD Million )
  37. France Preimplantation Genetic Testing Market By Product and Service, From 2019-2024 ( USD Million )
  38. France Preimplantation Genetic Testing Market By Application , From 2019-2024 ( USD Million )
  39. France Preimplantation Genetic Testing Market By End User , From 2019-2024 ( USD Million )
  40. Italy Preimplantation Genetic Testing Market By Procedure Type, From 2019-2024 ( USD Million )
  41. Italy Preimplantation Genetic Testing Market By Technology , From 2019-2024 ( USD Million )
  42. Italy Preimplantation Genetic Testing Market By Product and Service, From 2019-2024 ( USD Million )
  43. Italy Preimplantation Genetic Testing Market By Application , From 2019-2024 ( USD Million )
  44. Italy Preimplantation Genetic Testing Market By End User , From 2019-2024 ( USD Million )
  45. Spain Preimplantation Genetic Testing Market By Procedure Type, From 2019-2024 ( USD Million )
  46. Spain Preimplantation Genetic Testing Market By Technology , From 2019-2024 ( USD Million )
  47. Spain Preimplantation Genetic Testing Market By Product and Service, From 2019-2024 ( USD Million )
  48. Spain Preimplantation Genetic Testing Market By Application , From 2019-2024 ( USD Million )
  49. Spain Preimplantation Genetic Testing Market By End User , From 2019-2024 ( USD Million )
  50. Europe Blood Glucose Monitoring Market By Structural Chromosomal Abnormalities , From 2019-2024 ( USD Million )
  51. Europe Translocations Market By Region, From 2019-2024 ( USD Million )
  52. Europe Deletions Market By Region, From 2019-2024 ( USD Million )
  53. Europe Duplications Market By Region, From 2019-2024 ( USD Million )
  54. Europe Inversions Market By Region, From 2019-2024 ( USD Million )
  55. U.K. Blood Glucose Monitoring Market By Structural Chromosomal Abnormalities , From 2019-2024 ( USD Million )
  56. Germany Blood Glucose Monitoring Market By Structural Chromosomal Abnormalities , From 2019-2024 ( USD Million )
  57. France Blood Glucose Monitoring Market By Structural Chromosomal Abnormalities , From 2019-2024 ( USD Million )
  58. Italy Blood Glucose Monitoring Market By Structural Chromosomal Abnormalities , From 2019-2024 ( USD Million )
  59. Spain Blood Glucose Monitoring Market By Structural Chromosomal Abnormalities , From 2019-2024 ( USD Million )
  60. Europe Blood Glucose Monitoring Market By Structural Chromosomal Abnormalities , From 2019-2024 ( USD Million )
  61. Europe Translocations Market By Region, From 2019-2024 ( USD Million )
  62. Europe Deletions Market By Region, From 2019-2024 ( USD Million )
  63. Europe Duplications Market By Region, From 2019-2024 ( USD Million )
  64. Europe Inversions Market By Region, From 2019-2024 ( USD Million )
  65. U.K. Blood Glucose Monitoring Market By Structural Chromosomal Abnormalities , From 2019-2024 ( USD Million )
  66. Germany Blood Glucose Monitoring Market By Structural Chromosomal Abnormalities , From 2019-2024 ( USD Million )
  67. France Blood Glucose Monitoring Market By Structural Chromosomal Abnormalities , From 2019-2024 ( USD Million )
  68. Italy Blood Glucose Monitoring Market By Structural Chromosomal Abnormalities , From 2019-2024 ( USD Million )
  69. Spain Blood Glucose Monitoring Market By Structural Chromosomal Abnormalities , From 2019-2024 ( USD Million )
  70. Europe Blood Glucose Monitoring Market By Structural Chromosomal Abnormalities , From 2019-2024 ( USD Million )
  71. Europe Translocations Market By Region, From 2019-2024 ( USD Million )
  72. Europe Deletions Market By Region, From 2019-2024 ( USD Million )
  73. Europe Duplications Market By Region, From 2019-2024 ( USD Million )
  74. Europe Inversions Market By Region, From 2019-2024 ( USD Million )
  75. U.K. Blood Glucose Monitoring Market By Structural Chromosomal Abnormalities , From 2019-2024 ( USD Million )
  76. Germany Blood Glucose Monitoring Market By Structural Chromosomal Abnormalities , From 2019-2024 ( USD Million )
  77. France Blood Glucose Monitoring Market By Structural Chromosomal Abnormalities , From 2019-2024 ( USD Million )
  78. Italy Blood Glucose Monitoring Market By Structural Chromosomal Abnormalities , From 2019-2024 ( USD Million )
  79. Spain Blood Glucose Monitoring Market By Structural Chromosomal Abnormalities , From 2019-2024 ( USD Million )
  80. Europe Blood Glucose Monitoring Market By Structural Chromosomal Abnormalities , From 2019-2024 ( USD Million )
  81. Europe Translocations Market By Region, From 2019-2024 ( USD Million )
  82. Europe Deletions Market By Region, From 2019-2024 ( USD Million )
  83. Europe Duplications Market By Region, From 2019-2024 ( USD Million )
  84. Europe Inversions Market By Region, From 2019-2024 ( USD Million )
  85. U.K. Blood Glucose Monitoring Market By Structural Chromosomal Abnormalities , From 2019-2024 ( USD Million )
  86. Germany Blood Glucose Monitoring Market By Structural Chromosomal Abnormalities , From 2019-2024 ( USD Million )
  87. France Blood Glucose Monitoring Market By Structural Chromosomal Abnormalities , From 2019-2024 ( USD Million )
  88. Italy Blood Glucose Monitoring Market By Structural Chromosomal Abnormalities , From 2019-2024 ( USD Million )
  89. Spain Blood Glucose Monitoring Market By Structural Chromosomal Abnormalities , From 2019-2024 ( USD Million )
  90. Europe Blood Glucose Monitoring Market By Structural Chromosomal Abnormalities , From 2019-2024 ( USD Million )
  91. Europe Translocations Market By Region, From 2019-2024 ( USD Million )
  92. Europe Deletions Market By Region, From 2019-2024 ( USD Million )
  93. Europe Duplications Market By Region, From 2019-2024 ( USD Million )
  94. Europe Inversions Market By Region, From 2019-2024 ( USD Million )
  95. U.K. Blood Glucose Monitoring Market By Structural Chromosomal Abnormalities , From 2019-2024 ( USD Million )
  96. Germany Blood Glucose Monitoring Market By Structural Chromosomal Abnormalities , From 2019-2024 ( USD Million )
  97. France Blood Glucose Monitoring Market By Structural Chromosomal Abnormalities , From 2019-2024 ( USD Million )
  98. Italy Blood Glucose Monitoring Market By Structural Chromosomal Abnormalities , From 2019-2024 ( USD Million )
  99. Spain Blood Glucose Monitoring Market By Structural Chromosomal Abnormalities , From 2019-2024 ( USD Million )

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample